# Clinical Trial of HRS-4642 Plus SHR-A2102 in Patients With Advanced Solid Tumors

> **NCT06955390** · PHASE1,PHASE2 · NOT_YET_RECRUITING · sponsor: **Henan Cancer Hospital** · enrollment: 32 (estimated)

## Conditions studied

- Solid Tumors

## Interventions

- **DRUG:** SHR-A2102+HRS-4642

## Key facts

- **NCT ID:** NCT06955390
- **Lead sponsor:** Henan Cancer Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-05-01
- **Primary completion:** 2025-12-01
- **Final completion:** 2026-12-01
- **Target enrollment:** 32 (ESTIMATED)
- **Last updated:** 2025-05-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06955390

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06955390, "Clinical Trial of HRS-4642 Plus SHR-A2102 in Patients With Advanced Solid Tumors". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06955390. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*